New hope for tough Crohn's cases: experimental drug enters Mid-Stage testing
Disease control
Recruiting now
This study is testing whether an investigational drug called obefazimod can help control symptoms and reduce intestinal inflammation in adults with moderate to severe Crohn's disease who haven't gotten enough relief from standard treatments. Over 200 participants will receive eit…
Phase: PHASE2 • Sponsor: Abivax S.A. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC